2020 American Transplant Congress
Simultaneous Liver and Kidney Transplant Outcomes after “Safety Net” Policy Change
1University of Minnesota, Minneapolis, MN, 2Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Criteria for listing for Simultaneous Liver and Kidney (SLK) transplant changed on August 10, 2017. These changes were implemented to standardize the criteria for…2020 American Transplant Congress
One Year of the OPTN’s SLK Allocation Policy
*Purpose: Simultaneous Liver-Kidney (SLK) allocation policy went into effect on 8/10/17, establishing medical eligibility criteria for adult SLK candidates and creating a “Safety Net” for…2020 American Transplant Congress
Evolving Trends in Simultaneous Liver Kidney Transplant (SLKT) – Results from the US SLKT Consortium
*Purpose: The utilization of SLKT in the United States is rising in the MELD era. We aimed to understand the contemporary changes in characteristics and…2020 American Transplant Congress
Delayed Kidney Transplant (KT) up to 2 Days in Combined Liver-Kidney Transplantation (CLKT) Offers Similar Renal Function as KT Alone: Comparison Analysis with Mate Kidneys
*Purpose: Delayed KT in CLKT (Indiana Approach) offers a less hostile environment with hemodynamically more stable patient at the time of KT. Positive impact of…2020 American Transplant Congress
A Large Single Center Analysis of Medical and Surgical Complications Associated with Obesity after Kidney Transplantation in the Current Era
University of Wisconsin, Madison, WI
*Purpose: Medical and surgical complications associated with obesity after kidney transplantation in the current era are unknown.*Methods: We analyzed the records of consecutive first-time, kidney…2020 American Transplant Congress
Evaluation of an Intervention to Reduce Underdosing of Valganciclovir for Primary Prophylaxis of Cytomegalovirus Infection in Donor Seropositive/Recipient Seronegative Kidney and Liver Transplant Recipients
*Purpose: Valganciclovir (VCV) prophylaxis is used to prevent primary cytomegalovirus (CMV) infection in CMV donor seropositive/recipient seronegative (D+/R-) solid organ transplant recipients (SOT). We examined…2020 American Transplant Congress
No Kidney after Liver Left Behind: An Analysis of the Organ Procurement and Transplantation Network “Safety Net” Policy
Surgery, University of Cincinnati, Cincinnati, OH
*Purpose: Liver transplant (LT) recipients who develop persistent renal dysfunction face increased morbidity and mortality. These patients may be eligible for prioritization on the kidney…2020 American Transplant Congress
Discontinuation Rates in Multicenter Trials – Are They Driven by Attitudes or Facts?
*Purpose: The ATHENA [NCT01843348] and Hephaistos [NCT01551212] trials were designed to compare everolimus [EVR] in combination with reduced tacrolimus [rTAC] or reduced cyclosporine A [rCyA]…2020 American Transplant Congress
The Use of Scribes in Transplant Practice to Achieve Quality Outcomes and Foster Program Development
University Hospitals, Cleveland, OH
*Purpose: Transplantation is the most regulated surgical specialty in the US today. Transplant Centers (TC) are an increasingly pivotal component contributing to the fiscal viability…2020 American Transplant Congress
Living Donor Gender Disparities Vary by Donor-Recipient Familial Relationship
*Purpose: Women are more likely to be living transplant donors and less likely to be recipients. It has been difficult to distinguish how much of…
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 24
- Next Page »